Noul Co., Ltd.

Noul Co., Ltd. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Noul Inc. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing. Noul’s solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering. Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions. [Mission] We explore global challenges that threaten human health and life, discover novel potential solutions, and realize those possibilities. [Goal] 1. To contribute to eliminating malaria, tb, aids and other neglected diseases through innovative diagnostic platform. 2. To proactively increase healthcare accessibility through next-generation blood diagnostics platform.

Company Details

Employees
89
Founded
-
Address
338, Gwanggyojungang-Ro, Suji-Gu, Yongin-Si,, Umi-Newv Intelligence Industry Center,b,10th Floor,korea, Republic Of
Phone
82-31-308-6310
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
noul.kr
HQ
Yongin-si, Gyeonggi-do
Looking for a particular Noul Co., Ltd. employee's phone or email?

Noul Co., Ltd. Questions

News

Noul Signs Contract to Supply Malaria Diagnostic Solution to Ghana - Businesskorea

Noul Signs Contract to Supply Malaria Diagnostic Solution to Ghana Businesskorea

On-Device AI Healthcare Company Noul Becomes First Korean Diagnostic Company to Join Swiss Malaria Group - PR Newswire

On-Device AI Healthcare Company Noul Becomes First Korean Diagnostic Company to Join Swiss Malaria Group PR Newswire

Noul outperforms conventional clinical practices with breakthrough blood diagnostic platform - South China Morning Post

Noul outperforms conventional clinical practices with breakthrough blood diagnostic platform South China Morning Post

AI Diagnostic Platform Company Noul Releases 2022-2023 Sustainability Report - The Korea Herald

AI Diagnostic Platform Company Noul Releases 2022-2023 Sustainability Report The Korea Herald

Biotech Startup Noul Gets CE-IVD Mark for Two of miLab™ Cartridge Solutions - PR Newswire UK

Biotech Startup Noul Gets CE-IVD Mark for Two of miLab™ Cartridge Solutions PR Newswire UK

Noul wins Saudi FDA approval for malaria diagnosis device - 매일경제

Noul wins Saudi FDA approval for malaria diagnosis device 매일경제

Noul’s AI diagnosis of malaria outperforms human experts - koreabiomed.com

Noul’s AI diagnosis of malaria outperforms human experts koreabiomed.com

Noul's AI-based Blood Analysis Solution 'miLab BCM' Enters European Market - Businesskorea

Noul's AI-based Blood Analysis Solution 'miLab BCM' Enters European Market Businesskorea

Noul hits limit-up…obesity stocks rise [K-bio pulse] - 팜이데일리

Noul hits limit-up…obesity stocks rise [K-bio pulse] 팜이데일리

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant